Retatrutide A Game Changer in Obesity Pharmacotherapy (Biomolecules)
SURMOUNT-3 For the SURMOUNT-3 trial, patients who lost at least 5% of their body weight after a 12-week intensive lifestyle intervention lead-in period that included a low-calorie diet, exercise and weekly counseling sessions, were randomly assigned to receive either tirzepatide or placebo for 72 weeks to assess the efficacy and safety of the drug
Mental health challenges such as depression and low motivation are common among clients with hypothyroidism
Pure Med Spa emphasizes a medically supervised approach to ensure your weight loss is steady, healthy, and safe, setting realistic weight loss GLP-1 expectations from day one
Nicotinomide (vitamin B3) has been shown to be liver toxic in doses over 3G per day so observant of your daily and weekly intake
Unlike injectable GLP-1 receptor agonists, Rybelsus offers a convenient tablet formulation, approved by the EMA in 2020 and available on NHS prescription